Detalhe da pesquisa
1.
A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade.
Annu Rev Med
; 73: 231-250, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34644155
2.
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Oncologist
; 29(6): 493-503, 2024 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38330461
3.
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations.
Curr Opin Oncol
; 34(5): 559-569, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35787597
4.
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8597-8605, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36070113
5.
Clear cell carcinoma of the endometrium.
Gynecol Oncol
; 164(3): 658-666, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35063279
6.
Rag GTPases suppress PRL-3 degradation and predict poor clinical diagnosis of cancer patients with low PRL-3 mRNA expression.
Biochem Biophys Res Commun
; 576: 108-116, 2021 10 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34482023
7.
Uterine serous carcinoma.
Gynecol Oncol
; 162(1): 226-234, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33934848
8.
ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8608-8609, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36207480
9.
Targeting ATR in patients with cancer.
Nat Rev Clin Oncol
; 21(4): 278-293, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38378898
10.
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.
Clin Cancer Res
; 30(10): 2121-2139, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38416404
11.
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
Clin Cancer Res
; 28(11): 2248-2256, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35363275
12.
PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress.
Free Radic Biol Med
; 177: 72-87, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34662712
13.
Targeting the replication stress response through synthetic lethal strategies in cancer medicine.
Trends Cancer
; 7(10): 930-957, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34215565
14.
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1-Selective Inhibitors.
Cancer J
; 27(6): 521-528, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34904816
15.
Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises.
Trends Cancer
; 7(10): 958-970, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34158277
16.
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
Onco Targets Ther
; 14: 3921-3928, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34234460
17.
Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01).
Int J Radiat Oncol Biol Phys
; 109(3): 701-711, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33045316
18.
Targeting Cell Metabolism as Cancer Therapy.
Antioxid Redox Signal
; 32(5): 285-308, 2020 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31841375
19.
Reversal of Bowel Obstruction With Platinum-Based Chemotherapy and Olaparib in Recurrent, Short Platinum-Free Interval, RAD51C Germline Mutation-Associated Ovarian Cancer.
JCO Precis Oncol
; 2: 1-8, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35135172